Clinical neuropharmacology of hypothalamic releasing factors

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

The Journal of clinical endocrinology and metabolism·2008

Consensus statement: medical management of acromegaly.

European journal of endocrinology·2005

Diagnosis and treatment of acromegaly complications.

Journal of endocrinological investigation·2004

Growth hormone-releasing hormone and pituitary somatotrope proliferation.

Minerva endocrinologica·2003

The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.

Endocrinology·2001

The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.

Endocrinology·2001

Esophageal Cancer.

The New England journal of medicine·2026

Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy.

The New England journal of medicine·2026

Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.

The New England journal of medicine·2026

Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal.

The New England journal of medicine·2026

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

The Journal of membrane biology·2026

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Therapie·2026

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Handbook of experimental pharmacology·2026

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

The Journal of clinical endocrinology and metabolism·2026

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Nephron·2026

Related Experiment Videos

Clinical neuropharmacology of hypothalamic releasing factors

Related Concept Videos

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

Consensus statement: medical management of acromegaly.

Diagnosis and treatment of acromegaly complications.

Growth hormone-releasing hormone and pituitary somatotrope proliferation.

The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.

The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.

Esophageal Cancer.

Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy.

Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.

Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal.

Sarcolipin is a Conformation-Dependent Regulator of the Sarcoplasmic Reticulum Calcium Pump SERCA.

Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.

[Buprenorphine and pain management: Clinical insights and practical landmarks].

Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?

Phosphate storm in chronic kidney disease-mineral and bone disorder: practical clinical strategies for vascular calcification control.

Related Experiment Videos

Clinical neuropharmacology of hypothalamic releasing factors

Related Concept Videos

Related Articles